72 Grants (Page 1 of 3)
2018
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA075059-20), $441,940USD, 09/30/1997 -- 04/30/2019
 
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA075059-20S1), $3,579USD, 09/30/1997 -- 04/30/2019
2017
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA075059-19), $397,745USD, 09/30/1997 -- 04/30/2019
 
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA075059-19S1), $49,543USD, 09/30/1997 -- 04/30/2019
2016
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA075059-18S1), $58,398USD, 09/30/1997 -- 04/30/2019
 
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA075059-18), $441,940USD, 09/30/1997 -- 04/30/2019
2015
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA075059-17), $441,940USD, 09/30/1997 -- 04/30/2019
 
Novel aspects of Epithelial-Mesenchymal Transition(EMT)in pancreatic cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA075059-17S1), $54,821USD, 09/30/1997 -- 04/30/2019
2014
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA075059-16A1), $441,940USD, 09/30/1997 -- 04/30/2019
2012
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R37CA075059-15), $400,151USD, 09/30/1997 -- 05/31/2014
2011
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7R37CA075059-14), $417,605USD, 09/30/1997 -- 07/31/2013
2010
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R37CA075059-13), $452,707USD, 09/30/1997 -- 07/31/2011
 
Role of microRNAs in genetic mouse models of pancreatic cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R21CA135664-02), $139,113USD, 01/01/2009 -- 12/31/2011
2009
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R37CA075059-12), $462,645USD, 09/30/1997 -- 07/31/2013
 
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R37CA075059-11S1), $103,558USD, 09/30/1997 -- 07/31/2013
 
microRNAs as novel Biomarkers for Pancreatic Ductal Adenocarcinoma
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R21CA133715-02), $143,910USD, 08/01/2008 -- 07/31/2010
 
Role of microRNAs in genetic mouse models of pancreatic cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R21CA135664-01A1), $243,448USD, 01/01/2009 -- 12/31/2010
2008
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R37CA075059-11), $364,789USD, 09/30/1997 -- 07/31/2013
 
microRNAs as novel Biomarkers for Pancreatic Ductal Adenocarcinoma
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R21CA133715-01A1), $251,843USD, 08/01/2008 -- 07/31/2010
2007
Role of Glypican-1 in Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA101306-05), $320,862USD, 04/01/2003 -- 03/31/2009
 
Role of Neuropillins in Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA102687-05), $300,000USD, 09/30/2003 -- 06/30/2008
2006
CTSA Planning at Dartmouth Medical School
Korc, Murray
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 1P20RR023487-01), $239,850USD, 09/22/2006 -- 09/21/2008
 
Dysregulation of TGF Beta Action Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA075059-10), $347,417USD, 09/30/1997 -- 02/28/2008
 
Role of Glypican-1 in Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA101306-04), $330,445USD, 04/01/2003 -- 03/31/2008
 
Role of Neuropillins in Pancreatic Cancer
Korc, Murray
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA102687-04), $308,960USD, 09/30/2003 -- 06/30/2008